Top Clinical Trials companies in Norway by Operating Income Margin
This ranking features the top 4 Clinical Trials companies in Norway ranked by Operating Income Margin, averaging a Operating Income Margin of -13,802.37%, for February 07, 2025.
Norway
Clinical Trials
Operating Income Margin
Frequently Asked Questions
-
Which Clinical Trials company in Norway has the highest Operating Income Margin ?
The Clinical Trials company in Norway with the highest Operating Income Margin is Gentian Diagnostics ASA (Oslo Stock Exchange: GENT.OL) at -9.37%.
-
Which Clinical Trials company in Norway has the lowest Operating Income Margin ?
The Clinical Trials company in Norway with the lowest Operating Income Margin is BerGenBio ASA (Oslo Stock Exchange: BGBIO.OL) at -54,186.16%.
-
What are the top 10 Clinical Trials companies in Norway by Operating Income Margin ?
The top 10 Clinical Trials companies in Norway by Operating Income Margin are Gentian Diagnostics ASA, Lifecare AS, PCI Biotech Holding ASA and BerGenBio ASA.
-
What are the bottom 10 Clinical Trials companies in Norway by Operating Income Margin ?
The bottom 10 Clinical Trials companies in Norway by Operating Income Margin are BerGenBio ASA, PCI Biotech Holding ASA, Lifecare AS and Gentian Diagnostics ASA.
